Back to Stenocare or All Oil Concentrates

Details provided are based upon best-known information made available to MedBud, please reconfirm with your pharmacy. This product was last updated:
MedBud typically only updates products when availability changes, or new information is provided. An availability status from several months ago can still be valid when a product remains in/out of stock, or has been discontinued.

Medication Details

Brand
Denmark Stenocare
Designation
THC T30:C1
Chemotype
Type I: High THC
THC Potential Range (±10%)
27-33mg
CBD Potential Range (±10%)
0.9-1.1mg
Cultivated in
Flag of Denmark Denmark
Packaged in
Flag of Denmark Denmark
Imported by
United Kingdom Rokshaw

Stock Availability

We provide stock and pharmacy information for medical cannabis patients only. Cannabis is a controlled substance in the UK and can only be dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed here.

Best Known Status: Available

Main Partner Pharmacy

Pharmacy Wholesaler

Dispensing Pharmacies

Product DescriptionPatient Reviews

Denmark About Stenocare A/S

Stenocare Logo

Denmark's leading pharmaceutical supplier of medical cannabis. Stenocare is a publicly-traded Danish company that supplies prescription-based medical cannabis oils to patients in the Northern European and Australian market.

Stenocare grows, imports and distributes prescription-based medical cannabis oils.

Today, Stenocare operates in Denmark, Sweden, Norway, UK and Australia with 11 different prescription-based medical cannabis oil products for the treatment of pain and a variety of other conditions.

Stenocare works to ensure that doctors and patients can access a well-documented and pharmaceutical quality range of cannabis products. Stenocare operates in multiple countries, with a strong focus on providing prescription-based medical cannabis oils to patients.

Stenocare was the first Danish company to succeed in introducing prescription-based medical cannabis oil to Denmark, Sweden and Norway. The pharmaceutical products are monitored by the medicines agencies. Stenocare currently operates in Denmark, Sweden, Norway, UK and Australia and expects to have access to new markets in the coming years to enable more patients acquiring prescription-based medical cannabis.

Stenocare has received three permits from the Danish Medicines Agency to grow, handle and trade in narcotic substances as well as import and distribute medical cannabis in Denmark.

The Danish Medicines Agency controls and inspects companies that produce medicines – both before and after introduction to the market. The Danish Medicines Agency also controls companies that sell medicines. Only companies that have received written permission from the Danish Medicines Agency may produce and sell medicines in Denmark.

stenocare.com

  New government petition approved: Introduce 'Grow Your Own' Laws for Legal Medical Cannabis Patients (CBPM) — please sign and share. 6 months to achieve 10,000 signatures.

  Information provided is partially community-sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)